Specialty Chemicals

Chemspec

Chemspec released FY2026 Q1 earnings on April 23 After-Market (BJT), actual revenue CNY 149.88 M, actual EPS CNY -0.02

Chemspec to Release FY2026 Q1 Earnings on April 24 After-Market (BJT)

Chemspec to Release FY2025 Annual Earnings on April 24, 2026 Pre-Market BJT

Chemspec released FY2025 Q4 earnings on February 27 Pre-Market (BJT), actual revenue CNY 175.38 M, actual EPS CNY -0.0679

Chemspec released FY2025 Annual Earnings on February 27 Pre-Market (BJT), actual revenue CNY 771.56 M, actual EPS CNY -0.12

Chemspec released FY2025 Q3 earnings on October 30 After-Market (BJT), actual revenue CNY 159.74 M, actual EPS CNY -0.2313

Chemspec released FY2025 9 Months Earnings on October 30 After-Market (BJT), actual revenue CNY 596.18 M, actual EPS CNY -0.1706

Chemspec to Release FY2025 Q3 Earnings on October 31 After-Market (BJT)

Chemspec released FY2025 Q2 earnings on August 25 After-Market (BJT), actual revenue CNY 193.26 M, actual EPS CNY 0.0007

Chemspec released FY2025 Semi-Annual Earnings on August 25 After-Market BJT, actual revenue CNY 436.44 M, actual EPS CNY 0.06

Chemspec to Release FY2025 Semi-Annual Earnings on August 26, 2025 (BJT)

Kangpeng Technology Responds to SSE Inquiry on Slumping Profits

Kangpeng Technology shareholders collectively reduce holdings by 14.5751 million shares

Conpon Technology Shareholders Sell 10.5 Million Shares

Konpon Technology Financially Invests in Shanghai Zhongke Kangrun

Kangpeng Technology Inc. Net Loss in 2024, Turned from Profit to Loss

Chemspec released FY2025 Q1 earnings on April 17 After-Market BJT, actual revenue CNY 243.18 M, actual EPS CNY 0.06

Chemspec FY2025 Q1 Earnings Release Scheduled for April 18 After-Market BJT

Chemspec FY2024 Annual Earnings Release on April 18, After-Market BJT

Chemspec released FY2024 Q4 earnings on February 27 After-Market (BJT), actual revenue CNY 150.89 M, actual EPS CNY -0.1304

688602

Chemspec Europe will return to Cologne on May 6-7, 2026, with 75% of exhibition space already sold. Major industry players like Evonik and Johnson Matthey will showcase innovations across various sectors, including pharmaceuticals and agrochemicals. New initiatives include the Second-Year Exhibitor Zone and a two-stream conference focusing on strategic and technical topics. The event aims to facilitate high-quality connections among decision-makers, leveraging digital tools for enhanced engagement. Early interest highlights the event's importance for the fine and specialty chemicals sector amid current industry challenges.

WorldPharmaceuticals

Chemspec Europe Returns to Cologne in May 2026

Shareholders of Chemspec, Wuxi Yunhui and its concerted party Xingyu Huitian, announced a change in equity, with their shareholding ratio reduced to 5%. On August 2, they disclosed a reduction plan, intending to reduce no more than 15,581,250 shares. From September 29 to 30, they reduced 4,901,669 shares through centralized bidding transactions, with a total shareholding of 30,870,419 shares before the change, accounting for 5.94%; after the change, the total shareholding is 25,968,750 shares, with the ratio reduced to 5%. This reduction does not affect the company's controlling rights, and the reduction plan has not yet been fully implemented

Zhitong

Chemspec shareholders reduced their holdings, and after the change in equity, their shareholding decreased to 5%

000739

603456

603127

06127

688293

CRO concept stocks fluctuated upward, Jiuzhou Pharma hit the daily limit, APELOA rose over 5%, JOINN, Chemspec, OPM, and Haoyuan Pharma followed suit

APELOA

Jiuzhou Pharma

JOINN

CRO concept stocks fluctuate and rise, Jiuzhou Pharma hits the limit up

According to the Zhitong Finance APP, Chemspec disclosed its semi-annual report for 2025, showing that the company achieved revenue of 436 million yuan during the reporting period, a year-on-year increase of 27.94%; net profit attributable to shareholders was 31.02 million yuan, a year-on-year increase of 257.08%; net profit excluding non-recurring items was 23.36 million yuan, turning from loss to profit; basic earnings per share were 0.06 yuan

Chemspec released its semi-annual performance, with a net profit attributable to the parent company of 31.02 million yuan, a year-on-year increase of 257.08%

Chemspec announced that its shareholder Wuxi Yunhui and its concerted parties Xingyu Huitian, Tongxiang Jiawo, and its concerted party Tongxiang Yunhui plan to reduce their holdings by no more than 5.89%. Wuxi Yunhui and Xingyu Huitian plan to reduce a total of no more than 15,581,250 shares, accounting for 3% of the total shares; Tongxiang Jiawo and Tongxiang Yunhui plan to reduce a total of no more than 15,018,271 shares, accounting for 2.89% of the total shares

Multiple shareholders of Chemspec plan to reduce their holdings by no more than 5.89%

600642

000819

603256

001322

002660

On July 21, 23 listed companies had their restricted shares unlocked, with a total market value of approximately 5.36 billion yuan. The unlocking situation includes: Shangaohuan Energy (1.2772 million shares), YUEYANG XINGCHANG (2.1525 million shares), Zhangyu A (2.0357 million shares), Shenergy (9.7161 million shares), Batian Co., Ltd. (1.2 million shares), Wanma Co., Ltd. (2.6112 million shares), Chuanfa Longmang (12.5 million shares), Chengda Pharmaceutical (6.15594 million shares), Moso Power (8.22983 million shares), Laobaixing (193.6 thousand shares), Zhenbaodao (726.9 thousand shares), Lifang Pharmaceutical (234 thousand shares), Triangle Defense (1.104 million shares), Yidao Information (462.6 thousand shares), Grace (2.5265 million shares), Guomao Co., Ltd. (165.8 thousand shares), Arrow (1.3528 million shares), Hongying Intelligent (180 thousand shares), Chemspec (4.6189 million shares), Ju Yi Technology (2.1081 million shares), Xidiwei (3.154 billion shares), Aiko Optoelectronics (680 thousand shares), and Hangcai Co., Ltd. (3.18 million shares)

Shenergy

YUEYANG XINGCHANG

Grace

Arrow

Moso Power

Overview of the lifting of restrictions on the sale of A-shares | July 21

Chemspec Europe 2025 showcased the resilience of the fine and speciality chemicals industry, attracting 4,037 visitors from 62 nations and featuring 424 exhibitors. The event emphasized strong networking, with a 32.5% increase in digital connections and successful matchmaking. Attendees appreciated the comprehensive conference program, including discussions on market drivers and sustainable manufacturing. High satisfaction rates among exhibitors led to strong forward bookings for the next edition, scheduled for May 6-7, 2026, in Cologne, Germany.

Fine and speciality chemicals industry keeps its cool: Resilience and quality connections define Chemspec Europe 2025

301096

002821

06821

603669

CRO concept stocks saw a partial rise, with Lionco hitting the limit up, and Bio-S, Chemspec, JOINN, and Asymchem following suit

Bio-S

Asymchem

Lionco

CRO concept stocks partially rose, Lionco surged to the daily limit

On April 18th, Chemspec had a block trade of 8.8566 million shares, with a transaction amount of 76.5073 million yuan, accounting for 11.01% of the total transaction amount that day. The average transaction price was 8.64 yuan, which is a discount of 10.58% compared to the market closing price of 9.66 yuan, with the highest transaction price at 9.39 yuan and the lowest transaction price at 7.06 yuan

Chemspec today had a block trade of 8.8566 million shares, with a transaction amount of 76.5073 million yuan

According to the Zhitong Finance APP, Chemspec released its annual report for 2024, stating that the company's operating revenue for 2024 is 675 million yuan, a year-on-year decrease of 31.11%; the net loss attributable to shareholders of the listed company is 49.5316 million yuan, turning from profit to loss; the net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, is 93.5951 million yuan, turning from profit to loss; the basic loss per share is 0.10 yuan/share

Chemspec released its 2024 annual performance, with a net loss attributable to the parent company of 49.5316 million yuan, turning from profit to loss

Chemspec(688602.SH)